Clinical Trial Update: A Phase 2, Multicentre, Randomized, Double-blind, Placebo-controlled Study in Patients With New-onset Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 randomized trial in new-onset type 1 diabetes completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Dompé Farmaceutici S.p.A | Conditions: Diabetes Mellitus, Insulin-Dependent | Phase 2 | Status: COMPLETED | Results posted: 2021-01-12